Cargando…

QOL-11. COMPARISON OF TREATMENT BURDEN RATING SCALES ON NEUROCOGNITIVE OUTCOMES IN A MIXED SAMPLE OF PEDIATRIC BRAIN TUMOR SURVIVORS

BACKGROUND: Predicting neurocognitive outcomes in pediatric brain tumor (PBT) patients is challenging. Rarity of PBT makes inclusion of detailed risk factors (e.g., treatment modality, intensity, individual complications) difficult when sample sizes are small. The Neurological Predictor Scale (NPS)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baig, Muhammad, Olsthoorn, Ineke, Yang, Grace, Zaky, Wafik, Stavinoha, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Neuropsychology/Quality of Life
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715963/ http://dx.doi.org/10.1093/neuonc/noaa222.674

Ejemplares similares

QOL-28. NEUROCOGNITIVE PROFILE OF PEDIATRIC MEDULLOBLASTOMA PATIENTS PRIOR TO RADIATION THERAPY
por: Baig, Muhammad, et al.
Publicado: (2020)

QOL-10. Treatment-induced leukoencephalopathy in pediatric medulloblastoma survivors and its impact on long-term neurocognitive functioning
por: Wägner, Lukas, et al.
Publicado: (2022)

QOL-04. INFLUENCE OF FAMILY, SCHOOL, AND HOSPITAL SYSTEMS IN SUPPORTING SURVIVORS OF PEDIATRIC BRAIN TUMORS WITH NEUROCOGNITIVE LATE EFFECTS
por: Moscato, Emily, et al.
Publicado: (2020)

QOL-53. GENOME ASSOCIATIONS WITH NEUROCOGNITIVE OUTCOMES, CEREBRAL MICROBLEEDS (CMBS), AND BRAIN VOLUME AND WHITE MATTER (WM) CHANGES IN PEDIATRIC BRAIN TUMOR SURVIVORS
por: Kline, Cassie, et al.
Publicado: (2020)

QOL-11. Comparison of Neuropsychological Functioning in Pediatric Posterior Fossa Tumor Survivors: Medulloblastoma, Low-Grade Astrocytoma, and Healthy Controls
por: Levitch, Cara, et al.
Publicado: (2022)

QOL-04. Histology, treatment, and extent of pretreatment hydrocephalus are major determents of neurocognitive outcome for survivors of pediatric posterior fossa tumors - report from the German HIT-studies
por: Neumann-Holbeck, Anne, et al.
Publicado: (2022)

QOL-01. Inflammatory biomarkers and psychological sequela in pediatric brain tumor survivors
por: Turner, Emily, et al.
Publicado: (2022)

QOL-25. MICROSTRUCTURAL BRAIN CHANGES ASSOCIATED WITH NEUROCOGNITIVE AND FUNCTIONAL OUTCOMES OF INTRACRANIAL GERM CELL TUMUOR SURVIVORS – A DIFFUSIONAL KURTOSIS IMAGING STUDY
por: Tso, Wan-Yee Winnie, et al.
Publicado: (2020)

QOL-01. LONGITUDINAL COMPARISON OF NEUROCOGNITIVE TRAJECTORIES IN PEDIATRIC MEDULLOBLASTOMA PATIENTS TREATED WITH PROTON VERSUS PHOTON RADIOTHERAPY
por: Kahalley, Lisa, et al.
Publicado: (2020)

QOL-18. A LONGITUDINAL STUDY OF NEUROCOGNITION IN CHILDREN TREATED FOR A BRAIN TUMOR
por: Lemiere, Jurgen, et al.
Publicado: (2020)

QOL-06. QUALITY OF LIFE IN MEDULLOBLASTOMA SURVIVORS IN WESTERN MEXICO
por: del Campo, Regina M Navarro-Martin, et al.
Publicado: (2020)

QOL-02. PERCEPTIONS OF LATE EFFECTS CARE NEEDS AMONG SURVIVORS OF PEDIATRIC BRAIN TUMOURS
por: Cacciotti, Chantel, et al.
Publicado: (2020)

QOL-41. CARDIAC DYSFUNCTION IN MEDULLOBLASTOMA SURVIVORS TREATED WITH PHOTON IRRADIATION
por: Cacciotti, Chantel, et al.
Publicado: (2020)

QOL-17. Neurocognitive outcomes after treatment for medulloblastoma with reduced primary site target volume margins
por: Larkin, Trisha, et al.
Publicado: (2022)

QOL-16. A 6-year longitudinal study of neurocognition in children treated for a brain tumor
por: Bullens, Kristien, et al.
Publicado: (2022)

QOL-34. CAREER FAIR AND RESOURCE EXPO: ADVOCATING FOR THE LONG TERM SUCCESS OF BRAIN TUMOR SURVIVORS
por: Hoerig, Clay, et al.
Publicado: (2020)

QOL-15. NEURAL NETWORK INTEGRITY FOR FACIAL AFFECT RECOGNITION IN SURVIVORS OF MEDULLOBLASTOMA
por: Brinkman, Tara, et al.
Publicado: (2020)

QOL-07. CORTICAL VOLUME AND THICKNESS IN ADULT SURVIVORS OF CHILDHOOD POSTERIOR FOSSA TUMORS
por: Sleurs, Charlotte, et al.
Publicado: (2020)

QOL-44. ASSESSMENT OF NEUROCOGNITIVE FUNCTION AND MRI PARAMETERS IN LONG-TERM SURVIVORS WITH POSTERIOR FOSSA TUMORS: A COMPARISON BETWEEN MEDULLOBLASTOMAS TREATED BY REDUCED-DOSE CRANIOSPINAL IRRADIATION AND OTHER TUMORS
por: Kagawa, Naoki, et al.
Publicado: (2020)

QOL-12. CLINICAL SIGNIFICANCE OF RADIATION-INDUCED CEREBROVASULAR DISEASE IN CHILDHOOD BRAIN TUMOR SURVIVORS
por: Remes, Tiina, et al.
Publicado: (2020)

QOL-46. LATE EFFECTS CARE FOR CHILDHOOD BRAIN TUMOUR SURVIVORS: A QUALITY IMPROVEMENT PROJECT
por: Cacciotti, Chantel, et al.
Publicado: (2020)

QOL-38. USE OF COMPUTERIZED NEUROPSYCHOLOGICAL MEASURES TO ASSESS COGNITIVE MORBIDITY IN SURVIVORS OF CHILDHOOD BRAIN TUMORS
por: Dickson, Duncan, et al.
Publicado: (2020)

QOL-51. LISTENING BEFORE WE SPEAK: A PATIENT-CENTERED APPROACH TO DEVELOPING RESOURCES FOR PEDIATRIC BRAIN TUMOR SURVIVORS AND THEIR FAMILIES
por: Riley, Kathy
Publicado: (2020)

QOL-40. THE IMPACT OF TASK COMPLEXITY ON INFORMATION PROCESSING SPEED AND NEURAL COMMUNICATION IN PAEDIATRIC BRAIN TUMOUR SURVIVORS
por: Cox, Elizabeth, et al.
Publicado: (2020)

QOL-26. I’VE GOT FRIENDS NOW: PAEDIATRIC PATIENTS’ EXPERIENCES OF METHYLPHENIDATE TREATMENT FOR NEUROCOGNITIVE LATE-EFFECTS ASSOCIATED WITH BRAIN TUMOUR
por: Verity, Sarah, et al.
Publicado: (2020)

QOL-27. SWALLOWING ASSESSMENT IN PEDIATRIC PATIENTS WITH BRAIN TUMOR
por: Machado, Natalia Oliveira, et al.
Publicado: (2020)

QOL-08. Visual memory and potential clinical risk factors in long-term survivors of a childhood brain tumor
por: Sleurs, Charlotte, et al.
Publicado: (2022)

QOL-05. Cardiorespiratory fitness and health-related quality of life amongst survivors of childhood central nervous system tumours.
por: Keating, Rachael, et al.
Publicado: (2022)

QOL-48. INTERDISCIPLINARY SPIRITUAL CARE TRAINING IN PEDIATRIC NEURO-ONCOLOGY
por: Lion, Alex, et al.
Publicado: (2020)

QOL-58. ASSESSING FATIGUE EXPERIENCED BY PEDIATRIC PATIENTS WITH INTRACRANIAL NEOPLASMS
por: Eccles, Eamon, et al.
Publicado: (2020)

QOL-23. ASSESSING THE IMPACT OF METHYLPHENIDATE ON LATE COGNITIVE EFFECTS IN PAEDIATRIC BRAIN TUMOUR SURVIVORS: A SERVICE-BASED EVALUATION
por: Verity, Sarah, et al.
Publicado: (2020)

QOL-31. A psychosocial support program for young adult childhood cancer survivors in Austria: a qualitative evaluation study
por: Pletschko, Thomas, et al.
Publicado: (2022)

QOL-13. NEUROCOGNITIVE OUTCOMES ACCORDING TO RISK-ADAPTED TREATMENT REGIMENS FOR CHILDREN OLDER THAN 4 WITH MEDULLOBLASTOMA AND POSTERIOR FOSSA EPENDYMOMA – RESULTS OF THE HIT2000 TRIAL
por: Mynarek, Martin, et al.
Publicado: (2020)

QOL-17. BIOLOGICAL CORRELATES OF QUALITY OF SURVIVAL AND NEUROCOGNITIVE OUTCOMES IN MEDULLOBLASTOMA; A META-ANALYSIS OF THE SIOP-UKCCSG-PNET3 AND HIT-SIOP-PNET4 TRIALS
por: Chevignard, Mathilde, et al.
Publicado: (2020)

QOL-36. USE OF CANNABINOIDS IN THE PEDIATRIC CENTRAL NERVOUS SYSTEM TUMOR POPULATION
por: Dorris, Kathleen, et al.
Publicado: (2020)

QOL-07. The importance of an onco-fertility program for pediatric neuro-oncology patients
por: IJgosse, Irene, et al.
Publicado: (2022)

QOL-57. SOUTHERN CALIFORNIA KAISER PERMANENTE PEDIATRIC NEURO-ONCOLOGY PROGRAM DEVELOPMENT
por: Tran, Hung
Publicado: (2020)

QOL-55. INTEGRATED MULTI-SCALE MODEL FOR PEDIATRIC BRAIN TUMOR SURVIVAL PREDICTION
por: Qiu, Yeping Lina, et al.
Publicado: (2020)

QOL-43. ENDOCRINE AND METABOLIC CHANGES IN CHILDREN TREATED FOR MEDULLOBLASTOMA
por: Kalinin, Alexey, et al.
Publicado: (2020)

QOL-09. WHOLE-BRAIN WHITE MATTER NETWORK CONNECTIVITY IS DISRUPTED BY PEDIATRIC BRAIN TUMOR TREATMENT
por: Oyefiade, Adeoye, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_47b2slr7m7d26cr1h20dqv0db2